326 related articles for article (PubMed ID: 29514903)
41. Lysine residues of interferon regulatory factor 7 affect the replication and transcription activator-mediated lytic replication of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
Zhang T; Wang Y; Zhang L; Liu B; Xie J; Wood C; Wang J
J Gen Virol; 2011 Jan; 92(Pt 1):181-7. PubMed ID: 20844090
[TBL] [Abstract][Full Text] [Related]
42. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
43. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.
Vieira J; O'Hearn P; Kimball L; Chandran B; Corey L
J Virol; 2001 Feb; 75(3):1378-86. PubMed ID: 11152511
[TBL] [Abstract][Full Text] [Related]
44. OX40 and 4-1BB downregulate Kaposiās sarcoma-associated herpesvirus replication in lymphatic endothelial cells, but 4-1BB and not OX40 inhibits viral replication in B-cells.
Cho M; Myoung J
J Gen Virol; 2015 Dec; 96(12):3635-3645. PubMed ID: 26467721
[TBL] [Abstract][Full Text] [Related]
45. Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity.
Qi D; Hu L; Jiao T; Zhang T; Tong X; Ye X
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021902
[TBL] [Abstract][Full Text] [Related]
46. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.
Lu M; Suen J; Frias C; Pfeiffer R; Tsai MH; Chuang E; Zeichner SL
J Virol; 2004 Dec; 78(24):13637-52. PubMed ID: 15564474
[TBL] [Abstract][Full Text] [Related]
47. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
[TBL] [Abstract][Full Text] [Related]
48. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication.
Chang J; Renne R; Dittmer D; Ganem D
Virology; 2000 Jan; 266(1):17-25. PubMed ID: 10612656
[TBL] [Abstract][Full Text] [Related]
49. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
Liang Y; Ganem D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
[TBL] [Abstract][Full Text] [Related]
50. STING is dispensable during KSHV infection of primary endothelial cells.
Vogt D; Zaver S; Ranjan A; DiMaio T; Gounder AP; Smith JG; Lagunoff M
Virology; 2020 Jan; 540():150-159. PubMed ID: 31928996
[TBL] [Abstract][Full Text] [Related]
51. Kaposi's sarcoma-associated herpesvirus virions inhibit interferon responses induced by envelope glycoprotein gpK8.1.
Perry ST; Compton T
J Virol; 2006 Nov; 80(22):11105-14. PubMed ID: 16956942
[TBL] [Abstract][Full Text] [Related]
52. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
[TBL] [Abstract][Full Text] [Related]
53. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
[TBL] [Abstract][Full Text] [Related]
54. Kaposi's Sarcoma-Associated Herpesvirus Utilizes and Manipulates RNA N
Ye F; Chen ER; Nilsen TW
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592530
[TBL] [Abstract][Full Text] [Related]
55. Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.
Li S; Hu H; He Z; Liang D; Sun R; Lan K
PLoS Pathog; 2016 Oct; 12(10):e1005900. PubMed ID: 27760204
[TBL] [Abstract][Full Text] [Related]
56. Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45.
Zhu FX; Sathish N; Yuan Y
PLoS One; 2010 May; 5(5):e10573. PubMed ID: 20485504
[TBL] [Abstract][Full Text] [Related]
57. Suppression of lytic replication of Kaposi's sarcoma-associated herpesvirus by autophagy during initial infection in NIH 3T3 fibroblasts.
Jang GH; Lee J; Kim NY; Kim JH; Yeh JY; Han M; Ahn SK; Kang H; Lee M
Arch Virol; 2016 Mar; 161(3):595-604. PubMed ID: 26620587
[TBL] [Abstract][Full Text] [Related]
58. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
Cirone M
Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
[TBL] [Abstract][Full Text] [Related]
59. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction.
Bisson SA; Page AL; Ganem D
J Virol; 2009 May; 83(10):5056-66. PubMed ID: 19279093
[TBL] [Abstract][Full Text] [Related]
60. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
Zhang X; Wang JF; Kunos G; Groopman JE
Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
